Home/Filings/4/0000950170-25-027056
4//SEC Filing

Polymeropoulos Mihael Hristos 4

Accession 0000950170-25-027056

CIK 0001347178other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 7:38 PM ET

Size

5.0 KB

Accession

0000950170-25-027056

Insider Transaction Report

Form 4
Period: 2025-02-25
Polymeropoulos Mihael Hristos
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2025-02-25$4.46/sh+10,000$44,6402,331,730 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.445 to $4.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Documents

1 file

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001355537

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:38 PM ET
Size
5.0 KB